Caplight Logo









CardioFocus

CardioFocus

Private
Marlborough, MassachusettsHealthcare & Life Scienceshttps://www.cardiofocus.com

Last Round

Series E

Feb 23, 2023

Total Funding Raised

$252.11M

Company Overview

CardioFocus is a medical device company that specializes in innovative solutions for the precise treatment of atrial fibrillation through a comprehensive system of advanced devices, including a balloon catheter, endoscope, deflectable sheath, and integrated console.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

atrial fibrillation treatmentAFib treatmentcardiac ablationpulsed field ablationPFAlaser balloon ablationpulmonary vein isolationPVIendoscopic ablationelectrophysiology devicescardiac arrhythmiaPFA cathetermedtechrazor and blades modelrobotic pulsed field ablation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CardioFocus Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CardioFocus Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series EFeb 23, 2023
Series EApr 12, 2022
VC RoundJul 7, 2020
Series EMay 28, 2019
DebtJun 22, 2018
VC Round
Mar 29, 2017

Key People

Founding team and executive leadership

Curt Eyster

Chief Technology Officer

Executive Team

CardioFocus Investors

Notable investors and investment history

InvestorRounds
Kennedy Lewis Investment ManagementSeries E
Manatuck Hill PartnersSeries D, VC Round
SV Health InvestorsSeries D, VC Round, Series C, Series B
Fletcher SpaghtSeries D
Accuitive Medical VenturesSeries D, VC Round, Series C
Kestrel Venture ManagementSeries D, VC Round, Series B
Fletcher Spaght VenturesSeries D, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Expanded Pulsed Field Ablation (PFA) clinical programs.

  • Feb 3, 2026

    Presented late-breaking data at the AF Symposium 2026.

CardioFocus Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CardioFocus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CardioFocus's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarlborough, Massachusetts
Employee Range79
Year Founded1990
Last FundingFeb 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.